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Tissue engineering and biodegradable implants were developed to avoid problems caused 
by long-term use of non-metabolizing implants. Tissue engineering aspires to produce 
new tissues by using the patient’s own cells. Commonly, a porous three-dimensional (3D) 
scaffold is used as a supporting structure until enough new tissue has grown. Typical 
bioactive silicate glasses have many good qualities, such as their ability to bond to bone 
by forming a hydroxycarbonate apatite (HCA) layer, but due to their tendency to crystal-
lize during sintering and excessively long dissolution time, more suitable scaffold mate-
rials need to be developed. 
Borosilicate glasses based on commercial silicate glass S53P4 have emerged as a new 
and promising scaffold material due to their higher bioactivity and dissolution rate and 
better resistance to crystallization. In this thesis, three borosilicate glasses based on S53P4 
were studied and compared with the S53P4 glass. The glasses’ thermal properties, bioac-
tivity and dissolution were studied with differential thermal analysis (DTA), dissolution 
tests, inductively coupled plasma optical emission spectrometry (ICP-OES) and Fourier 
transform infrared spectroscopy (FTIR) to evaluate which composition has the most 
promising properties to be used as a tissue engineering scaffold material. Of these, DTA 
was used to determine the glasses’ ability to be processed at high temperatures by deter-
mining their thermal processing window (∆T). Dissolution tests were conducted by im-
mersing glass particle in simulated body fluid (SBF) and 2-amino-2-(hydroxymethyl)pro-
pane-1,3-diol (TRIS) solution for 6–168 h, and then measuring the pH of the solutions 
after each time point. From the obtained pH curves, dissolution rate and HCA layer for-
mation were observed. Ion release of the glass particles was further studied with ICP-
OES and structural changes in the glasses’ surface and precipitation of the HCA layer 
with increasing immersion time were studied with FTIR. 
Based on the results, borosilicate glasses dissolve quicker than S53P4 and they form a 
thicker and more crystallized HCA layer. B50 was the only borosilicate glass to have a 
wider ∆T than S53P4. Out of the three borosilicate glasses, B50 has the most promising 
properties concerning its use in tissue engineering as it has the widest ∆T, it dissolves the 
quickest and it forms the thickest and most crystallized HCA layer on its surface. 
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Kudosteknologia ja biohajoavat implantit kehitettiin, biohajoamattomien implanttien pit-
käaikaiskäytöstä aiheutuvien ongelmien välttämiseksi. Kudosteknologia pyrkii luomaan 
uusia kudoksia potilaan omien solujen avulla. Huokoista 3D-rakennelmaa käytetään usein 
tukemaan ympäröiviä kudoksia, kunnes uutta kudosta on muodostunut tarpeeksi. Tyypil-
lisillä bioaktiivisilla silikaattilaseilla on monia hyviä ominaisuuksia, kuten kyky sitoutua 
luuhun muodostamalla hydroksikarbonaattiapatiittikerros (HCA), mutta niillä on kuiten-
kin taipumus kiteytyä sintrauksen aikana ja niiden hajoaminen on erittäin hidasta, minkä 
vuoksi soveltuvampien tukirakennemateriaalien kehittäminen on tärkeää. 
Kaupalliseen S53P4-silikaattilasiin pohjautuvat borosilikaattilasit ovat nousseet esiin uu-
sina lupaavina materiaaleina, niiden korkeamman bioaktiivisuuden ja liukenemisnopeu-
den, sekä paremman kiteytymisenvastustuskyvyn vuoksi. Tässä kandidaatintyössä tutkit-
tiin kolmea eri borosilikaattilasia, jotka perustuivat S53P4-lasiin. Lasien termisiä ominai-
suuksia, bioaktivisuutta ja liukenemista tutkittiin differentiaalisen termisen analyysin 
(DTA), liuotuskokeiden, induktiivisesti kytketyn plasma-optisen emissiospektrometrian 
(ICP-OES) ja Fourier-muunnosinfrapunaspektroskopian (FTIR) avulla, jotta saatiin sel-
ville millä lasilla on parhaimmat ominaisuudet käytettäväksi kudosteknologiassa. DTA:ta 
käytettiin arvioimaan lasien kuumankestävyyttä määrittämällä niiden lämpökäsittelyik-
kuna (∆T). Liuotuskokeissa lasipartikkeleita liuotettiin kudosnestettä simuloivassa liuok-
sessa (SBF) ja 2-amino-2-(hydroksimetyyli)propaani-1,3-dioli (TRIS) liuoksessa 6–168 
tuntia, jonka jälkeen liuoksien pH mitattiin. Saatujen pH-kuvaajien avulla tutkittiin lasien 
liukenemisnopeutta ja HCA-kerroksen muodostumista. Lasipartikkeleista vapautuneiden 
ionein määrä mitattiin ICP-OES:n avulla. Lasin pintarakenteessa tapahtuvia muutoksia ja 
HCA-kerroksen muodostumista ajan edetessä tutkittiin FTIR:n avulla. 
Tulosten perusteella borosilikaattilasit liukenevat nopeammin kuin S53P4 ja ne muodos-
tavat paksumman ja kiteytyneemmän HCA-kerroksen niiden pinnalle. Lisäksi B50 oli 
ainoa borosilikaattilasi, jonka ∆T oli suurempi kuin S53P4:n. Tutkituista borosilikaatti-
laseista B50:llä on lupaavimmat ominaisuudet ajatellen sen käyttöä kudosteknologiassa, 
koska sillä on suurin ∆T, se liukenee nopeimmin ja sen pinnalle muodostuva HCA-kerros 
on paksuin ja kiteytynein. 
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1. INTRODUCTION  
A biomaterial is defined as a “material intended to interface with biological systems to evaluate, treat, 
augment or replace any tissue, organ or function of the body” by the European Society for Biomateri-
als [1]. Biomaterials include e.g. ceramics, metals, plastics and materials from biological sources [2]. 
In the beginning of the development of biomaterials the most important criterion of an implant was 
that it would be biologically inert. Biologically inert implants are passive constructions that support 
and replace tissues. In long-term use (10–20 years), non-metabolizing implants can cause problems, 
because metals can corrode, and plastics expire and become brittle. Both phenomena can cause 
chronic infections, pain, swelling and loosening or removal of an implant from body. To avoid these 
problems biodegradable implants were developed, and the research to improve existing implants and 
develop new ones is ongoing. The advantages of biodegradable implants are that they support or 
replace tissues until the tissues are healed, and then metabolize away before causing any long-term 
complications. Most biodegradable implant materials act passively but some materials, like certain 
glasses, are bioactive which accelerates the healing of damaged tissue. [3] 
A material is bioactive when it evokes a positive reaction at the tissue-material interface, which leads 
to the formation of a bond between the material and the surrounding tissues. A bioactive glass is a 
ceramic made, most commonly, from silica (SiO2), sodium oxide (Na2O), calcium oxide (CaO) and 
phosphorus pentoxide (P2O5). [4] The first bioactive glass was developed by Larry Hench in 1969. 
Before participating in a research project funded by the US Army, Hench was researching semicon-
ductors at the University of Florida. Hench and his team’s discovery of radiation resistant electronic 
materials led him to an US Army conference in 1967. On his way to the conference Hench met an 
Army colonel who, after listening to Hench’s discoveries about materials that can withstand exposure 
to high-energy radiation, asked Hench would it be possible to make a material that would tolerate the 
conditions inside a human body. The colonel further explained that current materials e.g. metals and 
polymers caused scar tissue to form around an implant, which increased the likelihood of the implant 
to be rejected by the body. Intrigued by the colonel’s sayings Hench wanted to start developing ma-
terials that, instead of eliciting scar tissue growth, would form a bond with the surrounding tissues 
(osseointegrate). [5, 6] After the conference Hench pitched the idea to his friend and together they 
submitted the research project idea to the US Army, which later resulted in the discovery of the first 
bioactive glass, 45S5 (Bioglass®). Bioglass® is composed out of SiO2 (46.1 mol-%), CaO (26.9 mol-
%), Na2O (24.4 mol-%) and P2O5 (2.6 mol-%). This specific composition was chosen because it is 
close to the ternary eutectic in a Na2O-CaO-SiO2 diagram. [5] 
Bioactive glasses can bond with bone tissue by forming a hydroxycarbonate apatite (HCA) layer 
which then interacts with the surrounding tissues and molecules. Due to their bone bonding ability, 
bioactive glasses are most commonly used in bone applications. [7]   
Tissue engineering is a multidisciplinary field which started in the US in the late 1980’s and has since 
been growing. Tissue engineering combines porous three-dimensional scaffolds that can be made, for 
example, from bioactive glass, with cells and growth factors to create structures that support and 
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replace tissues and stimulate new tissue growth until the tissue is healed. As new tissue grows, the 
scaffold degrades and finally, when the tissue is fully healed, the scaffold has completely degraded 
away. [3, 8] Bioactive glasses are often sintered into 3D-scaffolds, but the problem with silica glasses 
is that they start to crystallize in the temperatures used in sintering, which then decreases their bioac-
tivity [9, 10]. To decrease crystallization tendency and to improve bioactivity, many compounds, such 
as boron trioxide (B2O3) and magnesium oxide (MgO) have been added to the already existing silicate 
glass compositions, such as S53P4 (BonAlive®) [11, 12].  
The aim of this Bachelor of Science thesis is to study three different borosilicate glasses: B12.5, B25 
and B50 that are based on a silicate glass, S53P4. The studied properties were the glasses’ in vitro 
dissolution and thermal properties, and the aim was to determine which borosilicate glass composition 
has the best properties concerning its use as a tissue engineering scaffold material. The best properties 
are defined as the glass having a wider thermal processing window and a higher dissolution rate than 
S53P4 and the glass forms the thickest and most crystallized HCA layer. To determine which boro-
silicate glass composition seems most promising, the glasses’ thermal properties were studied to de-
termine their thermal processing window. Dissolution rate and HCA layer formation were studied 
with dissolution tests, by measuring the ionic concentration of the immersion solutions after certain 
time points and by studying the structural changes in the glasses’ surface layer.  
In the second chapter of this thesis, the theorical background of bioactive glasses is described. First 
the properties of silicate glasses are addressed and then how adding boron affects the glass properties. 
The third chapter describes the sample preparation and methods used to study in vitro and thermal 
properties of the selected glasses. In the fourth chapter, the results are presented, analyzed and dis-
cussed.  The fifth and final chapter has the conclusions of this study. 
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2. THEORETICAL BACKGROUND 
This chapter first describes the basics of glass structure and its properties. Then the dissolution pro-
cess, thermal properties and applications of bioactive glasses are explained. Last the effects of boron 
addition in bioactive glass properties are addressed. 
2.1 Glass Properties and Structure  
Glasses are amorphous materials, which means that the atoms in the lattice have no long-range order 
unlike in crystalline materials [11, 13]. Due to their amorphous structure glasses do not have a precise 
melting point, but they soften over a temperature range [14].  Another characteristic of amorphous 
materials is glass transition which will be explained in detail in Section 2.5. Below glass transition 
glasses are hard materials, so they have good abrasion resistance but, on the other hand, glasses are 
also brittle and vulnerable to stress concentrations which complicates their use in load-bearing appli-
cations [11, 15].  
 
The basic components of a glass structure are network formers, network modifiers and intermediate 
oxygens. Network formers like SiO2, P2O5 and B2O3 form the basis of a glass by connecting to each 
other via oxygen atoms called bridging oxygen atoms. In silica glasses the silica atoms are connect 
to four oxygen atoms creating a 3D-structure. Network formers can be the only components in a glass 
network, but usually there are also network modifiers and intermediate oxides in the structure. Net-
work modifiers are e.g. alkali and alkaline earth metal cations (Na+, K+, Ca2+) that disrupt the glass 
structure by turning the bridging oxygen atoms into non-bridging oxygen atoms. Covalent bonds 
connecting the oxygen atoms to other atoms turn predominantly into ionic linkages (Si-O-Si  Si-O-
M+, where M+ is a network modifier cation). [11] With silicate-based glasses, when the covalent 
cross-linking deceases due to the increase of network modifiers, the glass’s softening temperature 
decreases. The glass also become chemically more unstable, which enables atoms to move around 
more at elevated temperatures, increasing the glasses’ tendency to crystallize. [16] Intermediate ox-
ides, on the other hand, can behave like typical network modifiers or can potentially enter the back-
bone of the glass structure and behave almost like network formers. Although, intermediate oxides 
complicate the glass structure because they can switch their role in the glass, they can, for example, 
decrease the tendency of a bioactive glass to crystallize. [11] 
 
Network connectivity tells how many bridging oxygen atoms there are per network-forming compo-
nent in the glass structure, i.e. how cross-linked the glass network is. Glasses with low network con-
nectivity have a lower glass transition temperature (Tg), higher solubility and higher reactivity than 
glasses with higher network connectivity. Network connectivity of bioactive glasses is usually 2–3. 
[11, 17] 
2.2 Bioactivity and Dissolution of Bioactive Glasses 
Bioactivity of a material is defined as the ability of bioactive materials to evoke a positive reaction at 
the tissue-material interface, which leads to the formation of a bond between the material and the 
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surrounding tissue [4, 8]. There are three features, which separate bioactive glasses from conventional 
ones. Bioactive glasses contain less than 60 mol-% of SiO2, they have high Na2O and CaO content, 
and a high CaO/P2O5 ratio, which leads them to have a highly reactive surface when exposed to an 
aqueous medium [18]. Bioactive glasses form a bond with the surrounding tissue by forming an HCA 
layer. There are five stages in the HCA layer formation, in body fluid in vivo (inside of body) or in 
simulated body fluid (SBF) in vitro (outside of body), for silicate-based glasses. Glasses that contain 
less silica have a lower network connectivity and therefore dissolve more rapidly meaning that the 
following stages happen more quickly. [7] In stage 1, network modifiers exchange ions (Na+, K+, 
Ca2+ with H+ or H3O
+) with the surrounding body fluids or SBF. Silica groups in the glass network 
hydrolyze because of the rapid ion exchange. [4, 8] 
Si— O— Na+ + H+ → Si— O − H+ +  Na+ (aq)  (1) 
In stage 2, because of the hydrolysis pH of the surroundings increases it leads to the dissolution of 
SiO2, formation of silicic acid (Si(OH)4) into the solution and the formation of Si-OH (silanols) on 
the glass surface. [4, 8] 
Si— O— Si + H2O → Si— OH + Si— OH  (2) 
In stage 3, the amorphous SiO2-rich layer condensates and polymerizes on the surface of the glass, 
which is depleted in alkalis and alkaline earth cations. [4, 8]  
  (3) 
In stage 4, the dissolution process of the glass network continues, and Ca2+ and PO4
3- ions from the 
glass network migrate through the SiO2-rich layer and form a CaO-P2O5-rich layer on top of it. After 
the CaO-P2O5-rich layer has formed, it grows by obtaining the soluble Ca
2+ and PO4
3- ions from the 
surrounding solution and connects them into the existing structure. [4, 8] 
In stage 5, the glass network dissolves further and the CaO-P2O5-rich layer crystalizes. The CaO-
P2O5-rich layer crystalizes to an HCA layer by intaking OH
-, CO3
2- ions from the solution. [4, 8] 
Bioactive glasses precipitate primarily into HCA instead of hydroxyapatite (HA) in SBF because SBF 
is supersaturated towards HCA precipitation [19, 20]. 
The increase of pH due to the ion exchange in stage 2 causes bioactive glasses to have antibacterial 
properties. It has been shown that S53P4 has growth-inhibiting properties towards 17 anaerobic bac-
teria and 29 clinically important aerobic bacteria in vitro. In addition, S53P4 exhibits antibacterial 
properties in lower concentrations and it has the fastest killing or growth-inhibiting effect towards 
anaerobic bacteria compared to 13-93 and CaPSiO II bioactive glasses. [11, 21, 22] Products that 
come from the degradation and dissolution of bioactive glasses induce osteoinduction [7]. In osteoin-
duction, dissolution products stimulate genes that in turn stimulate progenitor cells to differentiate 
into osteoblasts (cells that produce bone), and, as a result, new bone is formed (osteogenesis) [6, 23]. 
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Other terms related to the bioactivity and bone formation are osteoconductivity and osteostimulation. 
Osteoconductive glasses provide a surface along which or into the bone tissue, blood capillaries and 
perivascular tissue can grow, whereas glasses that are osteostimulation can improve and actively 
stimulate proliferation and differentiation of progenitor cells. [6, 24, 25] 
2.3 Applications of Bioactive Glasses 
Bioactive glasses are commonly used in tissue engineering. Tissue engineering is a multidisciplinary 
field that combines e.g. cellular biology, material sciences and biochemistry in creating new tissues 
and organs from patient’s own cells [3]. Most commonly, a porous 3D-scaffold is produced from a 
biodegradable material in which cells and/or growth factors can be incorporated either outside the 
body (in vitro) or inside the body (in vivo or in situ) [3, 8]. Other scaffold materials besides ceramics 
are synthetic and natural polymers [1].  
Bioactive glasses are most commonly used in bone repair applications because of their ability to form 
HCA, which closely resembles crystalline HA found in bones [17, 26]. Bone is the second most 
transplanted tissue after blood, and usually autografts are used. Autografts are grafts that are taken 
from another part of the patient, which means that there is no risk of foreign body reaction. [7, 27] 
Allografts, in turn, are taken from a different individual of the same species, while xenografts are 
taken from a different species. Both allografts and xenografts can cause a foreign body reaction. [28–
30]  
Foreign body reaction occurs at the end-stage of an inflammatory and wound healing process in which 
a fibrous capsule is formed around a foreign object e.g. biomaterial or an implant [30]. The fibrous 
capsule that isolates the object from the surrounding tissues, and prevents it from spreading, forms 
because the body’s immune system cannot eliminate the intruder by phagocytosis or phagolysosomal 
digestion [31]. It is critical to understand the mechanism of foreign body reaction because it can affect 
the biocompatibility, safety and function of a device, implant or a tissue-engineering structure [30]. 
While there are many advantages in using allografts, such as having no risk of foreign body reaction 
as mentioned previously, the downside of using allografts is their limited supply and pain caused to 
the donor site due to extraction operation [7, 27]. 
There are many criteria for a bioactive glass scaffold. The scaffold must be biocompatible, which is 
defined as the scaffold fulfilling its intended purpose of supporting cellular activity, to maximize 
tissue regeneration without eliciting adverse effects at a local or systemic scale [32]. The scaffold 
needs to degrade into non-toxic products that can be metabolized away at the same rate as the new 
tissue is formed [8]. The mechanical properties need to match the tissue that the scaffold is going to 
replace, and the scaffold should maintain its mechanical strength until enough new tissue is formed. 
To allow cell penetration and diffusion of nutrients and waste to and away from the cells, the porosity 
of the scaffold needs to be at least 50 %, preferably over 90 % and the pore size at least 100 μm, 
preferably 100–500 μm. In addition, the pores need to be interconnected. [8, 10] The scaffold material 
must allow processing into relevant shapes, manufacturing of the scaffold should be cost-effective, 
and the manufacturing process must be suitable for small- and large-scale production. Finally, the 
finished scaffold must be capable of being sterilized. [1, 8] 
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2.4 Sintering and Thermal Properties of Glasses 
One method of producing bioactive glass scaffolds is sintering. Sintering is needed when scaffolds 
are made from glass particles in order to fuse the particles together to form a solid structure [7]. In 
viscous sintering, a powdered glass is heated close to, or above its softening temperature, and then 
compressed to form a solid structure [33]. The densification is caused by viscous flow. Surface ten-
sion gradients drive the material flow towards the particle necks, and eventually the particles combine 
decreasing the porosity and shrinking the powder compact. [34] Parameters that affect the sintering 
process and the characteristics of the final product are, for example, processing temperature, material 
composition, and particle size and packing [33]. 
 
Thermal analysis is an analysis method intended for measuring the change of a physical property as 
a function of temperature in a temperature-controlled environment [35]. One method of analysis is 
differential thermal analysis (DTA, also called heat flux DSC). Properties that can be measured with 
DTA are, for example, glass transition temperature, onset temperature of crystallization and melting 
point. [36] 
 
In glass transition, liquid transforms to a glass, over a temperature range, when cooled rapidly [37]. 
The cooling rate needs to be fast enough to prevent the material from reaching an equilibrium at any 
temperature, which would lead to the formation of crystals [38]. When cooled down enough the long-
range motion of molecule chains becomes prevented [39]. Glass transition temperature (Tg) is a tem-
perature where the viscosity of the material is 100 TPa [40]. Glassy state is a metastable state, mean-
ing that the system is not in an equilibrium and its lifetime is exceptionally long compared to excited 
states of atoms [41]. The thermodynamically stable state for a glassy material at low temperatures is 
crystalline solid. Glass transition changes the properties of glass, such as the heat capacity and thermal 
expansion coefficient. [38] 
 
Crystallization begins with nucleation, which then leads to the formation of crystals [42]. Nucleation 
starts at a temperature where the viscosity of the glass melt is low enough to allow atomic rearrange-
ment and diffusion. Before crystals can form, the nuclei need to reach a critical radius to become 
stable. Nuclei with a radius smaller than the critical value dissolve due to their unstable nature. The 
critical radius increases as the temperature increases, leading it to be infinite at melting point. Crys-
tallization starts when nuclei have reached the critical size and the temperature is high enough for the 
atoms to rearrange into an ordered structure i.e. crystals. [43]  
2.5 Thermal Properties of Silicate-based Bioactive Glasses 
Typical silicate bioactive glasses crystallize easily during hot processing [9, 10]. Temperatures used 
to hot process the glasses causes them to crystallize which means that it is not possible to fully sinter 
them before crystals start to form [10]. One of the reasons why bioactive glasses tend to crystallize 
relatively easy is because of the glass network’s low network connectivity due to a large concentration 
of non-bridging oxygen atoms. The large amount of oxygen atoms reduces the covalent cross-linking 
between the silicate chains, which enables the structural units to move around more, which further 
advances the formation of critical size nuclei. [11]  
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Silicate glasses crystallize into silica phases, and it has been found that S53P4 crystallizes into two 
different crystalline phases because of their low phosphate content, which, in turn, decreases their 
bioactivity and solubility [9-11, 44]. Bioactivity and solubility decrease when the degree of crystal-
linity increases, because the molecules in the crystals are organized into an ordered structure which 
restricts the movement of the amorphous regions, thereby preventing molecules to pass through the 
material surface which delays the HCA layer formation (in SBF) [45, 46]. In addition, the crystallized 
areas in a glass increase the network connectivity of the remaining glass phase. Some secondary 
crystalline phases have even been found to be insoluble in SBF and 2-amino-2-(hydroxymethyl)pro-
pane-1,3-diol (TRIS) solution. Crystallization also decreases the reaction rate and causes an uncon-
trollable release of ions. [10] 
 
The ability of a bioactive glass to be processed at high temperatures can be roughly approximated by 
calculating the temperature difference between the onset of crystallization (Tx) and the glass transition 
temperature (Tg). This temperature range in which viscosity allows sintering and other processing 
methods is called the thermal processing window (∆T). [11] A large ∆T predicts that viscous flow 
happens before crystallization, and if a bioactive glass has a small ∆T, then the nucleation and crys-
tallization are more likely to happen prior, during or after sintering because they are so close to the 
Tg [45].  
 
The tendency of a bioactive glass to crystallize can be reduced in many ways. One way is by increas-
ing their network connectivity, but if the network connectivity is too high, then the bioactivity and 
solubility of the glass start to decrease. Another way is to reduce the amount of alkaline and alkaline 
earth metal cations in the structure. The reduction of these network modifiers lowers the Tg and in-
creases the Tx which leads to a larger ∆T. With a higher number of components in the glass, it is 
possible to increase entropy of mixing which raises activation energy of critical size nuclei formation, 
and thereby hinders the crystallization. Adding intermediate ions, such as magnesium, strengthens 
the bonds in the glass structure which widens the ∆T but it also increases the network connectivity 
which, after a certain point, starts to decrease the glass’s solubility and degradation, as mentioned 
before. [11] A more recent method is to add B2O3, another network former, into the composition. 
Borosilicate glasses have a lower crystallization rate than silicate (and boron) glasses, which increases 
their possibility to be sintered without crystallizing [10]. Section 2.6 explains more in detail how the 
addition of boron affects the crystallization of glass. 
2.6 Borosilicate Glasses 
Bioactive borosilicate glasses are silica-based and they contain boron trioxide (B2O3) [47-51]. Be-
cause of boron (B), borosilicate glasses have lower chemical durability than silicate glasses, which is 
caused by the replacement of SiO2 with B2O3. Boron has a coordination number of 3 which means 
that it cannot fully form a three-dimensional network like silicon (Si) [47, 49, 52]. Lower chemical 
durability speeds up the dissolution process, which leads to a more complete conversion to HCA 
compared to other silicate-based bioactive glasses [47-49]. Although borosilicate glasses do not fully 
convert to HCA, the sodium (Na) and boron ions in the unconverted glass dissolve entirely into the 
surrounding solution, so that in the end there is a sodium and boron ion depleted SiO2-rich core which 
is surrounded by an HCA layer [47, 48]. The conversion of borosilicate glasses is initially controlled 
by dissolution of the glass and later by diffusion. As borosilicate glasses dissolve in SBF, basic alkalis 
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and alkaline earth cations (Na+ and Ca2+) and hydroxide from the hydrolysis of silica are released. In 
addition, BO3
3- ions are released into the surrounding solution from the hydrolysis of borate sites in 
the glass structure, and PO4
3- ions are taken in from the solution to form a CaO-P2O5-rich layer. As 
boric acid is a weaker acid than phosphoric acid pH of the surrounding solution increases. [49] In 
solutions that do not contain PO4
3-, the increase in pH is due to the hydrolysis of borate and silica in 
the glass network and the release of basic alkalis and alkaline earth cations [53]. 
It has been found that while the conversion rate to HCA is greater for borosilicate glasses than silicate-
based glasses, the boron ion concentrations higher than 0.65 mmol (in solution) mmol decrease the 
proliferation of osteoblast-like cells and the growth and proliferation of bone marrow cells. The de-
crease is due to the toxic nature of the boron leached from the glass. [54] However, the boron released 
from bioactive glasses has shown no toxic effects in vivo [8, 55]. The ability to support cell differen-
tiation and proliferation in vitro can be increased by mixing the cell culture by shaking it to make the 
system more dynamic. Another way is to convert the surface layer of the borosilicate glass to HCA 
by pre-reacting it in an aqueous phosphate solution before adding it to the culture medium. [8] Boron 
concentrations under 0.65 mmol support the proliferation of bone marrow stromal cells and the pro-
liferation and function of osteogenic MLO-A5 cells in vitro [50, 51]. In addition to stimulating angi-
ogenesis (formation of new blood vessels) in vivo and in vitro, boron released from the dissolution 
of borosilicate glasses also increases the proliferative and migratory response, tubule formation ca-
pacity and secretion of pro-angiogenic cytokines of human umbilical vein endothelial cells in vitro 
[11, 55]. Boron released from the dissolution of borosilicate glasses supports soft tissue infiltration 
and extra cellular matrix formation in vivo and enhances bone formation more than silicate glasses 
[50, 51]. In addition, it has been found that at least borosilicate glass 13-93B1 can fully convert to 
HCA in vivo [51].   
Borosilicate glasses crystallize into silicate phases, and it has been found that probably all borosilicate 
glasses form at least two different crystal phases when crystallizing [10]. Borosilicate glasses crys-
tallize primarily from the surface and crystallization is most likely surface-controlled rather than dif-
fusion-controlled [10, 11, 45]. Surface crystallization has two main downsides. The first one is that 
the crystals at the surface will be in contact with the solution. If the crystals are too stable, the solution 
will not be able to hydrolyze the amorphous phase. [56, 57] The second downside is that surface 
crystallization can inhibit viscous flow, thereby making sintering more difficult [11]. Borosilicate 
glasses based on S53P4 generally have a wide thermal processing window and a low activation energy 
for viscous flow, which makes them suitable for processing via sintering [10].  In a study [45], it was 
found that at least S53B50 can be sintered without it crystallizing. When compared to silicate glasses, 
borosilicate glasses have lower Tg, Tx, Tp and forming temperature due to the addition of B2O3. B2O3 
is unable to form a fully 3D-glass network causing the network to be more loosely packed. [10, 47] 
 
The tendency of a borosilicate glass to crystallize can be decreased by using a large particle size 
because small particle size increases crystallization by increasing the surface nucleation sites [45]. 
The amount of added alkali oxides, alkaline earth oxides and boron can also influence glass proper-
ties. B2O3 can appear in two forms trigonal planar [BO3] and tetrahedral [BO4] depending on the glass 
composition. When alkali oxides, such as Na2O or K2O, are incorporated into the glass network, the 
trigonal [BO3] units convert to tetrahedral [BO4]. The conversion from [BO3] to [BO4] happens only 
up to a certain alkali oxide concentration after which the number of non-bridging oxygens increases 
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reversing the changes in properties caused by the [BO4] units. [BO4] units increase the network con-
nectivity of the glass structure, which decreases the glasses solubility and bioactivity. This behavior 
of borate containing glasses is called boron anomaly. The conversion of [BO3] to [BO4] and increase 
of non-bridging oxygens can also happen when alkaline earth oxides are incorporated into the glass 
network. [58–60] In addition, glasses with only [BO3] units have shown to have better resistance to 
crystallization.  The amount of B2O3 effects the conversion of [BO3] to [BO4] in a way that in smaller 
quantities, B2O3 appears in [BO3] form in the glass but when the B2O3 quantity is increased the [BO3] 
units transform into [BO4]. [59] It has also been found that only a small number of the [BO3] and 
[BO4] units are incorporated into the silica network. Due to the phase separation, it can be said that 
the glass network contains silicate and borate sub-networks. [58] 
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3. EXPERIMENTAL PART 
In this chapter, the methods and procedures used to conduct the experiment are presented. First, the 
manufacturing of the glass samples is explained, and after that, the different methods used to study 
the in vitro dissolution and thermal properties. The goal of this experimental part was to determine 
how the addition of B2O3 to S53P4 glass affects the properties of glass and which composition: B12.5, 
B25 or B50 has the best properties when considering their potential use as tissue engineering scaffold. 
3.1 Preparing the Glass Samples 
The glass samples were prepared by mixing 99.4 % pure SiO2 in the form of Belgian quartz sand and 
analytical grades of H3BO3, Na2CO3 and NH4H2PO4 or CaHPO4·2H2O from Sigma-Aldrich and 
CaCO3 from ThermoFisher GmbH. The borosilicate glass samples were made by substituting 12.5, 
25 or 50 % of the SiO2 with H3BO3 in the S53P4 glass. The S53P4 glass was used a reference material 
and prepared along with the other samples.  
Before the melting process all the components were mixed and grinded further in mortar. The glasses 
were melted in a platinum crucible in an LHT 02/07 LB furnace (Nabertherm GhmB, Lilienthal, 
Germany) by heating them up to 1250 – 1400 °C depending on the glass composition. After that the 
melted glass was cast onto a graphite mold and put into a pre-heated electrical oven (L 5/11 or L 3/12, 
Nabertherm) for 5 h at 500 °C for annealing. Annealing is done to release internal stresses and insta-
bilities that form inside the glass due to rapid cooling and would then complicate further processing 
[61, 62]. After the annealing was done, the glass samples were left to cool down to room temperature 
inside the oven. Compositions of the glass samples in mol-% are presented in Table 1 and the com-
plete thermal processing cycle is presented in Table 2.  
Table 1. Compositions of the glass samples in mol-%. 
Oxide type S53P4 B12.5 B25 B50 
SiO2 55.76 47.12 41.84 27.90 
B2O3 - 6.73 13.95 27.88 
CaO 18.99 21.77 18.99 18.99 
Na2O 23.47 22.66 23.46 23.46 
P2O5 1.78 1.72 1.76 1.78 
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Table 2. Thermal processing cycle of the glass samples. 
Step Time (min)   Final temperature (°C) 
Heating (10 °C/min) 60  650 
Holding 30  650 
Heating (10 °C/min) 20  850 
Holding 30  850 
  Glass  
Heating to melting tem-
perature (10 °C/min) 
55 S53P4 1400 
50 B12.5 1350 
 45 B25 1300 
 40 B50 1250 
Holding 45  
At melting tempera-
ture 
Casting into a graphite mold and transferring into a pre-heated electrical 
oven. 
Annealing 300  500 
Cooling Over night Room temperature 
 
In the last sample preparation step, the glasses were crushed in a metal mortar and then sieved with 
test sieves (Fritsch GmbH, Idar-Oberstein, Germany) to 125–250 μm particles. A Retsch AS 200 
sieve shaker (Retsch GmbH, Haan, Germany) was used to separate the glass particles 
3.2 Differential Thermal Analysis 
Thermal properties of the glass samples were studied with differential thermal analysis (DTA). DTA 
measures the temperature difference between a sample and a reference (∆TDTA) which are placed 
symmetrically in a furnace, which is then heated at a constant rate. The temperature difference is 
measured by two thermocouples, one in contact with the sample crucible and the other with the ref-
erence crucible. ∆TDTA changes from zero to either positive or negative when thermal events, such as 
crystallization or melting, occur in the sample. If the thermal event is endothermic (absorbing heat), 
then the ∆TDTA is negative and if the event is exothermic (releases heat), the ∆TDTA is positive. [63] 
The direction of endothermic or exothermic events depends on the machine and in graphs it is marked 
with an arrow. Then the obtained ∆TDTA is converted to heat flow rate (dq/dt) with calorimetric cali-
bration and it can be presented as a function of time or temperature [64]. The DTA curves of the 
samples were measured using a STA 449 F1 Jupiter® (Netzsch-Gerätebau GmbH, Selb, Germany) by 
placing 30 mg of sample inside a platinum-rhodium crucible with a lid placed on top of it and heating 
it up to 1250 °C at a 10 °C/min heating rate in a nitrogen atmosphere. The purity of the nitrogen gas 
was 99.95 % and the flow rate inside the DTA chamber was 20 ml/min. In addition, a 20 ml/min 
protective nitrogen gas flow was used to protect the balance from any corrosive fumes. An empty 
crucible was used as a reference.  
Tg, Tx and Tp were determined from the DTA curves and then ∆T (∆𝑇 = 𝑇𝑥 − 𝑇𝑔) was calculated using 
the obtained data. An example of a DTA curve and methods used to determine the temperatures in 
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question are presented in Figure 2. In all the DTA figures obtained from the measuremts the exother-
mic events are upwards and the endothermic events are downwards. 
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Figure 2. DTA curve of B12.5 glass showing the determination methods of Tg, Tx and Tp. 
Tg was defined as the inflection point of the first order deviation in the thermogram. The inflection 
point is measured at the minimum of the DTA curve’s first derivate. Tx was determined from the 
intersection of tangents of the plateau and the crystallization peak following it. Tp was obtained as the 
maximum of the crystallization peak. 
3.3 In Vitro Dissolution 
In vitro bioactivity and dissolution behavior of the glass samples were studied by means of dissolution 
tests conducted in SBF and in TRIS buffer solution. The SBF solution was prepared by following the 
protocol presented by Kokubo et. al (Shown in appendix A) [65]. One liter of TRIS (pH ~7.4/37 °C) 
was prepared by dissolving 1.66 g of 2-amino-2-(hydroxymethyl)-1,3-propanediol and 5.72 g of 
tris(hydroxymethyl)aminomethane hydrochloride into distilled water. Dissolution tests were carried 
out by immersing 75 mg of each glass in 50 ml of SBF or TRIS for 6, 24, 48, 72 or 168 hours in a 37 
°C incubator (Termaks B 8133, Bergen, Norway). Each glass composition had three parallel samples 
and the pH of the SBF and TRIS solutions without any glass particles was monitored with two control 
samples at each time point. After each time point, the pH of the sample solutions was measured at 37 
± 0.2 °C with S47-K SevenMulti™ pH-meter (Mettler-Toledo LLC, Ohio, USA). One milliliter of 
each sample solution was pipetted into a centrifuge tube for inductively coupled plasma optical emis-
sion spectrometry (ICP-OES) and the remaining glass particles were filtered with suction filtration 
and dried for the Fourier transform infrared spectroscopy (FTIR). 
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3.4 Inductively Coupled Plasma Optical Emission Spectrometry 
The concentration of released ions in the SBF or TRIS solution after each time point was measured 
with ICP-OES 5110 (Agilent Technologies, California, USA). ICP-OES measures the intensity of 
light emitted by excited ions in the sample solution, which depends on the concentration of the ion. 
The wavelength of the emitted light is characteristic to each element. Radio frequency current created 
by a generator causes an oscillating magnetic field. This created electromagnetic field ionizes argon 
gas and accelerates the released electrons flowing inside the plasma torch. When using liquid samples, 
the sample solution is transformed into a liquid aerosol by pumping it through a nebulizer into the 
high-speed argon gas flow. Collisions between the sample ions and electrons causes the ions to be-
come excited. When the ions go back to the ground state, they emit light, of which intensity is related 
to the concentration of the ion. [66, 67]  
For the ICP-OES a specific wavelength was chosen for each element, which are presented in Table 
3.  
Table 3. Measured wavelength for each element. 
Element B Ca Na P Si 
Wavelength 
(nm) 249.678 422.673 589.592 253.561 250.690 
 
Samples for the ICP-OES were prepared by pipetting 1 ml of each sample solution from the dissolu-
tion tests at each time point into a 15 ml centrifuge tube and diluted with 9 ml of 1 M nitric acid to 
ensure that all the components stay dissolved and do not precipitate [68]. Nitric acid is used because 
it does not cause chemical or spectral interferences and most elements used in bioactive glasses are 
soluble in it [69].  
3.5 Fourier Transform Infrared Spectroscopy 
Structural changes in the glass particles during the dissolution process were monitored by measuring 
the spectrum with FTIR. In FTIR the infrared radiation is guided through an interferometer (usually 
a Michelson interferometer). Michelson interferometer consists of three components: a source of IR 
radiation, a stationary mirror, and a moving mirror. The two mirrors are perpendicular to each other 
and in the middle of the three components there is a beam splitter. The beam splitter transmits half of 
the coming radiation to the stationary mirror and reflects the other half to the moving mirror. After 
the two radiation beams reflect off their respective mirrors they recombine at the beam splitter, as 
presented in Figure 3. [70, 71] 
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Figure 3. Diagram of a Michelson interferometer [72]. 
The path length of the radiation varies depending on the position of the moving mirror. When the two 
beams recombine at the beam splitter they interfere with each other either constructively or destruc-
tively depending on the path length differences. Next, the recombined beam leaves the interferometer 
and interacts with the sample before striking a detector.  The frequency of the infrared radiation 
changes at a specific rate and if the dipole moment of a molecule changes at the same rate as the 
frequency, the infrared radiation is absorbed by a bond in the molecule. The intensity of an absorbance 
peak must exceed a certain threshold value before it can be detected. Radiation frequencies not ab-
sorbed by the sample reach the detector producing an interferogram. In the interferogram the intensity 
of the absorbance (or transmittance) is plotted as the function of the path length difference, also 
known as retardation. To get the data into an interpretable form, Fourier transformation is used to 
convert the signal from time domain into frequency domain. When the signal is in frequency domain, 
a plot of intensity as a function of frequency, or more commonly wavenumber, known as spectrum, 
can be produced. [70, 71] 
The FTIR spectra of the glass samples were measured before and at each immersion time point of the 
dissolution tests with a Spectrum One FT-IR Spectrophotometer (PerkinElmer Inc., Massachusetts, 
USA) using an attenuated total reflectance (ATR) accessory. The spectra were measured between 
650–4000 cm-1 and 8 accumulations scan were conducted with a 4 cm-1 resolution. The obtained 
spectra were background corrected and normalized to the peak with the highest intensity. 
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4. RESULTS AND DISCUSSION 
In this chapter, results from the experimental part are presented and analyzed. Results from different 
glass compositions are compared to one another in order to find out which composition has the most 
promising results to be used as a tissue engineering scaffold. 
4.1 Thermal Properties 
DTA measurements were conducted to see how B2O3 addition affects the glasses’ ∆T. The DTA curve 
for each glass composition is presented in Figure 4. Thermal parameters Tg, Tx, and Tp as well as the 
thermal processing window determined from the DTA curves are presented in Table 4.  
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Figure 4. DTA curves of the glass samples. 
Table 4.  Thermal parameters (Tg, Tx and Tp) and thermal processing window (∆T) of each glass 
composition. 
Thermal parameter S53P4 B12.5 B25 B50 
Tg (± 3 °C) 563 532 525 513 
Tx (± 3 °C) 710 661 656 679 
Tp (± 3 °C) 757/785 757 706 720 
∆T = Tx - Tg (± 6 °C) 147 129 131 166 
 
The thermal parameters of each borosilicate glass sample were lower than the corresponding values 
of S53P4, as expected. When comparing the Tg, Tx and Tp values of the borosilicate glasses to each 
other, it is noticeable that Tg decreases as the B2O3 content increases, as it should but Tx and Tp of 
B50 are higher than the corresponding values of B25. When comparing the thermal processing win-
dows, ∆T increases with the increasing B2O3 content, but ∆T for B12.5 and B25 glasses is lower that 
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of S53P4. When looking at the intensities of the crystallization peaks it can be noticed that the inten-
sity of B12.5 is much higher that of S53P4, but the intensity of B25 is much lower than that of S53P4. 
For B50 the intensity of the crystallization peak is between S53P4 and B25. S53P4 has two crystalli-
zation peaks as expected, but none of the borosilicate glasses show two crystallization peaks although 
it has been studied that borosilicate glasses likely form two crystal phases [10].  
When comparing the results with previous studies [10, 73], the results are mainly in line with the 
previous results. The main difference is that in the previous studies ∆T values of borosilicate glasses 
were always larger than that of S53P4. The differences between the results can partially be explained 
by particle size difference. Smaller particles have a smaller ∆T due to the increase of nucleation sites 
and the difference in ∆T between S53P4 and borosilicate glasses is also smaller for smaller glass 
particles, as indicated in study [45]. 
As B50 has the largest ∆T, it has the most potential to be sintered without it crystallizing and, as was 
mentioned in Section 2.7, B50, with 125–250 μm particle size, can be sintered without crystal for-
mation. B50 with < 38 μm and 250–500 μm-sized particles can also be sintered without crystal for-
mation, as shown in studies [10, 73]. In addition to B50, B12.5 and B25 can also be sintered without 
them crystallizing, as shown in studies [10, 12, 73]. So, even though B12.5 and B25, with 125–250 
μm particle size, have a smaller ∆T than S53P4, they can most likely be sintered without crystal 
formation.  
4.2 In Vitro Dissolution and Bioactivity 
Dissolution tests were carried out by immersing the glass particles in SBF or TRIS for 6–168 h at 37 
°C and then the pH of the solution was measured. The tests were carried out to study how B2O3 
addition effects the dissolution rate and HCA layer formation. The pH of the SBF and TRIS solutions 
for each glass composition after each time point are presented in Figure 5.  
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Figure 5. pH of the a) TRIS and b) SBF solution with glass particles immersed in it after each 
time point. 
In the dissolution test with TRIS the pH of the solution increased with time and with increasing B2O3 
content. In TRIS the pH values for B50 are higher than for B25, unlike in SBF indicating that B50 
would dissolve quicker than B25. All the measured pH values for TRIS were higher than for SBF 
indicating that the glasses dissolve quicker in TRIS. In a recent study [74] the effect of chloride ions 
in TRIS on the dissolution of bioactive glasses was studied. Significantly higher chloride concentra-
tion, than from the dissolution of bioactive glasses, can cause hydroxyl in HA to be replaced by 
chloride, forming a chlorapatite layer [74]. In the study [74], it was found that high chloride concen-
trations do not cause significant differences in the HA or HCA layer formation.  
In the dissolution test with SBF the pH of the solutions increased with time and up to B25, and then 
interestingly the pH values for B50 are almost the same as for B25 indicating that B50 would dissolve 
at the same rate as B25. The use of SBF for testing the bioactivity and bone bonding ability of bioac-
tive glasses has been criticized because: (i) The manufacturing procedure is complicated. (ii) The 
solution is not filtered at any point, which increases the risk of insoluble contaminants. (iii) SBF 
solution is already supersaturated towards HCA precipitation. [19, 20] Compared to a previous study 
[75] conducted with 250–500 μm particles, the obtained pH values obtained in this work agree with 
the previous results. 
In both solutions, TRIS and SBF, the dissolution rate is more rapid in the first 72 h and then it slows 
down, but all in all the dissolution of each glass composition is quite controlled. The borosilicate 
glasses dissolved quicker than S53P4 in both solutions, which is positive because S53P4 dissolves 
too slow [10]. B50 dissolves the quickest as the dissolution rate increases with the increasing B2O3 
content. The formation of the HCA layer is connected to the dissolution, so based on the test results, 
B50 should form the thickest HCA layer. 
The ion release and the dissolution rate of the glass samples was further studied with ICP-OES. Figure 
6 presents the percentage of a) B, b) Si, c) Ca, d) Na and e) P ions in TRIS as a function of immersion 
time. The percentage of ions in SBF and the ionic concentration of each ion in TRIS and SBF as a 
function of immersion time are presented in Appendix B.   
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Figure 6. Percentage of a) B, b) Si, c) Ca, d) Na and e) P ions in TRIS as a function of immersion 
time.  
Figures 6 a) and b) present the changes is B and Si ions in TRIS, which act as the network formers in 
the glass structure. The more B2O3 there is in the glass, the more it is released into the TRIS solution. 
It can also be detected that B-O-B bonds are less resistance to hydrolysis than Si-O-Si bonds because 
only 13–32 % percent of the Si ions in the glass are released in 168 h compared to the 63–88 % of 
the B ions being released in the same time. The increasing B2O3 content also slightly increases the 
dissolution rate of the silica network because as the B2O3 content increases water can more easily get 
into the glass structure increasing the interaction surface area between water and silicate network. 
Also, when there is less silica in the glass, the surface to volume ratio of the sub-network increases, 
which can increase its dissolution rate. [53] Interestingly, when substituting 12.5 % of the SiO2 with 
B2O3, it causes only a slight 1.4 percentage point (pp) increase in the release of Si ions compared to 
S53P4 and even when 25 % of the SiO2 is substituted with B2O3 there is also only 4.1 pp difference 
in the release of B and Si between B25 and B12.5. However, when 50 % of the SiO2 is substituted 
with B2O3, there is greater 14.2 pp difference in the release of B and Si compared to B25.  
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Changes in the Ca and Na ion content in TRIS are presented in Figures 6 c) and d). The release of Na 
ions increases with increasing B2O3 content due to the fact that Na in the borate sub-network is re-
leased quicker because B in released quicker than Si. Also, Na in the silicate sub-network is released 
quicker when the B2O3 content increases due to more Si being soluble as seen in Figure 6 b). As for 
Ca ions, the same percentage of Ca ions is released from S53P4 and B12.5, but then for B25 the 
percentage of released Ca ions increases by 18 % (compared to S53P4 or B12.5). The increase be-
tween B25 and B50, in turn, is 19 %. A more thorough structural analysis would be required to evi-
dence the affinity of Ca to enter the silicate or borate sub-network. According to the ICP-OES release 
curves the release rate of B, Ca, Na and Si ions is more rapid in the first 72 h and then it slows down, 
as expected. The ion release of P is presented in Figure 6 e). All the release curves differ considerably 
from each other. With all the other glasses, except for B25, the percentage of released P decreases. 
Over all, because the percentage of released ions is different for each ion, the dissolution process of 
the glasses is non-congruent. Pure silica glasses dissolve congruently, which causes excessively long 
degradation times as S53P4 glass has been found in body even after 14 years of implantation. [10] 
Borate glasses, in turn, dissolve congruently. Based on the dissolution test and ICP-OES results even 
though borosilicate glasses dissolve non-congruently their dissolution is quite controlled and quicker 
than that of S53P4. 
Figure 7 presents the ionic concentration of a) B, b) Si, c) Ca, d) Na and e) P ions in SBF as a function 
of immersion time. 
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Figure 7. Ionic concentration (ppm) of a) B, b) Si, c) Ca, d) Na and e) P ions in SBF as a function 
of immersion time. 
 
Figures 7 a) and b) present the changes is B and Si ions in SBF. The changes in B and Si ion concen-
trations in SBF with increasing time are very similar to the ones obtained with TRIS. The concentra-
tion B and Si ions is almost the same in SBF and TRIS. Based on the release curves of B and Si in 
SBF, B50 dissolves quicker than B25 despite its pH did not rise more that of B25.  
Changes in the Ca and Na ion in SBF are presented in Figures 7 c) and d). The release curves of Ca 
for B12.5, B25 and B50 in SBF are slightly different than the corresponding curves for TRIS. The 
biggest difference is that for S53P4 the concentration of Ca ions decreased during the first 72 h and 
then it stayed almost the same. Also, less Ca ions were released in TRIS than in SBF. The concentra-
tion of Na ions in the SBF solution increased for all the borosilicate glasses and decreased for S53P4. 
In SBF, the release on Na ions also increased with increasing B2O3 content but the differences be-
tween the glasses are not as big as in TRIS. The ion release of P in presented in Figure 7 e). The 
concentration of P ions in the SBF solution decreased for every glass, but the intake rate of the P ions 
decreased with increasing B2O3 content. The release curves of P ions in SBF differ from the ones in 
TRIS because SBF contains PO4
3- ions, which are used in the formation of the CaO-P2O5-rich layer. 
When comparing the ionic concentration curves, presented in Figure 7, to the ones obtained in a 
previous study [75], the ionic concentration curves of B and Ca are very similar in both studies but 
there are slight differences in the Si and P ion curves. In the study [75], the Si concentration of B25 
and B50 started to decrease after 72 h and the P concentration started to increase, which did not 
happen in this study. 
The obtained ICP-OES results support the information obtained from the dissolution tests. The ion 
release curves show that the dissolution rate increases with increasing, B2O3 content, as the percent-
age of released the B and/or Si ions is highest for B50 and the lowest for S53P4.  
The FTIR spectrum of each glass sample was measured after each time point to observe the possible 
HCA layer formation and how the dissolution affects the surface structure of the glasses. Figure 8 
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presents the FTIR spectrum of each glass composition before the dissolution tests, and Figure 9 pre-
sents the spectrum of S53P4 and B50 after each time point immersed in TRIS or SBF. FTIR spectra 
of all the glass samples after each time point immersed in TRIS and SBF are presented in Appendix 
C. 
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Figure 8. FTIR spectrum of each glass composition before the dissolution tests. 
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Figure 9. FTIR spectrum of S53P4 and B50 after each time point immersed in TRIS or SBF. 
For S53P4 a band at 745–800 cm-1 is caused by bending vibration of Si-O and symmetric stretching 
of Si-O-Si bonds in the [SiO4] tetrahedral. With increasing immersion time, the band shits to a higher 
wavenumber. A band at 875 cm-1, which appears after 48 h in SBF and after 72 h in TRIS, is caused 
by CO3
2- in the glass structure, which in bioactive glass is typically assigned to a carbonated reactive 
layer. A peak at ~930 cm-1 is attributed to Si-O- stretching of the non-bridging oxygen atoms and it 
shifts to higher wavenumber and its intensity decreases with increasing immersion time due to the 
dissolution of the glass network. [10, 20, 76–78]  C-O vibrations of the CO32- group and P-O-P bonds 
cause a shoulder at ~ 960 cm-1, which intensity increases with increasing time [77]. A peak at ~1020 
cm-1 is caused by asymmetric stretching of Si-O-Si bonds and stretching of P-O bonds. The peak at 
~1020 cm-1 shifts to a higher wavenumber after 6 h and its intensity increases but after 6 h the intensity 
and the wavenumber stay approximately the same. [10, 20, 76, 77] A band at 1150–1250 cm-1 is 
caused by P=O stretching and the intensity of the band increases with increasing immersion time [78]. 
Lastly, the band at 1400–1550 cm-1 is also caused by CO32- in the glass [10, 20, 76, 77]. Overall, the 
FTIR spectra shows the dissolution of the soluble silica and the precipitation of carbonated calcium 
phosphate, which can be assigned to HCA in bioactive glasses.  
Borosilicate glasses have all the same peaks and bands as S53P4, in addition, to the ones caused by 
B2O3 in the glass network. When B2O3 is added, the peaks at ~930 cm
-1 and ~1020 cm-1, which are 
caused by vibrations of silica in the glass network, broaden due to vibrations caused by B-O-M (where 
M stands for a network modifier atom), B-O-Si and B-O-B bonds. [10] With increasing B2O3 content: 
(i) The band at ~745 cm-1, which is caused by vibrations of Si-O and Si-O-Si bonds decreases and 
shifts to a lower wavenumber forming a new band at 715 cm-1 (for B50), which grew in intensity as 
the B2O3 content increased. The new band is caused by bending of the B-O-B bonds and it shifts to a 
higher wavenumber and its intensity decreases with increasing immersion time. (ii) The intensity of 
a peak at 875 cm-1, which is caused by vibrations of CO3
2- in HCA, [BO4] and P-O, increases. The 
intensity of the peak increases also in time. (iii) A band caused by vibrations of [BO2O
-] at 1160–
1270 cm-1 appears and increases in intensity. (iv) A shoulder appears at 1330 cm-1, which is caused 
by stretching of [BO3] triangles. (v) The stretching of [BO3] triangles cause a band at 1300–1550 cm-
1, which partially overlaps with the band caused by CO3
2- in HCA at 1400–1550 cm-1. As the B2O3 
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content increases the peak of the band shifts to a lower wavenumber (to 1390 cm-1). With increasing 
immersion time peak of the band shifts slightly to a higher wavenumber with some of the glass sam-
ples. [10, 79] In both solutions, the initial dissolution of the glass backbone is faster with increasing 
B2O3 content. 
As seen from Figure 9 b) and d), an HCA layer formed on the surface of each glass composition in 
TRIS and SBF, but the precipitated HCA layer was thinner in TRIS than in SBF. Based on the disso-
lution tests and ICE-OES results it seems that the thickness of the formed HCA layer increases with 
increasing B2O3 content. The formed HCA layer of B12.5 is slightly thinner that of S53P4 based on 
the FTIR results, but the used measuring technique (ATR) can influence the obtained spectra. In ATR, 
because the glass particles are pressed against the crystal the outermost layer, which is the HCA layer, 
can be damaged revealing the layer underneath it with a different composition, which changes the 
obtained spectrum. B50 has the thickest and most crystallized reactive layer on its surface, which can 
be seen from Figures 9 b) and d). The peak at ~1020 cm-1, which is caused by P-O and Si-O-Si bonds, 
is the narrowest, and the peak at ~875 cm-1, which is caused by P-O, CO3
2- and [BO4], has the highest 
intensity. B50 has the least amount of carbonate present in the formed reactive layer, which can be 
seen from Figure 9 d). The band at 1400–1500 cm-1, which is caused by CO32-, has the lowest inten-
sity. The reason for this anomaly is still unknown. As the difference in the carbon content between 
the glasses is so small, it most likely does not cause any noticeable differences in interaction between 
the reactive surface layer and the surrounding tissues and cells. 
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5. CONCLUSIONS 
In this Bachelor of Science thesis, three different borosilicate glass composition based on commercial 
the S53P4 glass were produced along with S53P4. The glasses’ thermal properties, in vitro dissolution 
and bioactivity were studied to determine which composition would be the most suitable to be used 
as a tissue engineering scaffold material. 
DTA was used to determine the glasses thermal properties. The obtained result for B50 agree with 
previous studies that out of these four glasses B50 has the widest thermal processing window. In 
several previous studies conducted with different particle sizes, B50 has successfully been sintered 
without it crystallizing. The DTA results for B12.5 and B25 did not agree with previous studies, as 
their thermal processing window was narrower than that of S53P4. In vitro dissolution and bioactivity 
were studied with dissolution tests in SBF and TRIS, ICP-OES and FTIR. The dissolution test pH-
curves showed that borosilicate glasses dissolve quicker than S53P4 and that the dissolution rate 
increases with increasing B2O3 content. In addition, based on the pH curves the dissolution of boro-
silicate glasses was quite controlled. The ICP-OES and FTIR results supported the information from 
the pH-curves, and the formation of an HCA layer could clearly be seen from the FTIR spectra. All 
the obtained results from the dissolution tests mostly agreed with previous results indicating that 
borosilicate glasses with desired properties can be quite easily reproduced. 
Based on all the results, the most promising glass to be used in tissue engineering seems to be B50 
because it has the widest ∆T, it dissolves the quickest and it formed the thickest and most crystallized 
HCA layer on its surface after 168 h.  
Overall, borosilicate glasses seem very promising materials for tissue engineering and several studies 
concerning e.g. scaffold production, addition of magnesium or strontium into the glass network, the 
use of luminescence particle to enable optical imaging, and how borosilicate glasses and their disso-
lution products effect human adipose stem cells have already been conducted [10, 12, 75, 80]. How-
ever, further cell compatibility studies with glass particles and scaffolds need to be done to fully 
understand how borosilicate glasses affect cells and to optimize the glass composition. 
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APPENDIX A: PRODUCTION OF SBF 
1 liter of SBF solution for the dissolutions test was produced by adding the reagents shown in Table 
A.1 5 to 700 ml of distilled water. The reagents were added slowly into the water letting each reagent 
to fully dissolve before adding the next. Approximately 35 ml of 1 M HCl was added into the solution 
after the MgCl2 and the rest of the HCl was reserved for adjusting the pH to 7.40 ± 0.02 at 37.0 ± 0.2 
°C after each reagent was dissolved. After the pH was adjusted, the volume was adjusted to 1 liter. 
Table A.1. Reagents and the amounts needed to produce SBF. 
Or-
der Reagent Amount  
1 NaCl 7.996 g 
2 NaHCO3 0.350 g 
3 KCl 0.224 g 
4 K2HPO4·6H2O 0.228 g 
5 MgCl2 0.305 g 
6 HCl (1M) ~40 ml 
7 CaCl2·2H2O 0.368 g 
8 Na2SO4 0.071 g 
9 (CH2OH)3CNH2 6.057 g 
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APPENDIX B: ICP-OES RESULTS 
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Figure B.1. Percentage of 1) B, 2) Si, 3) Ca, 4) Na and 5) P ions in SBF as a function of immersion 
time. 
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Figure B.2. Ionic concentration (ppm) of 1) B, 2) Si, 3) Ca, 4) Na and 5) P ions in TRIS as a func-
tion of immersion time. 
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APPENDIX C: FTIR SPECTRA 
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Figure C.1. FTIR spectrum of 1) S53P4, 2) B12.5, 3) B25 and 4) B50 after each time point im-
mersed in TRIS. 
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Figure C.2. FTIR spectrum of 1) S53P4, 2) B12.5, 3) B25 and 4) B50 after each time point im-
mersed in SBF. 
 
 
